681 related articles for article (PubMed ID: 28762987)
1. Autoreactive T cells in type 1 diabetes.
Pugliese A
J Clin Invest; 2017 Aug; 127(8):2881-2891. PubMed ID: 28762987
[TBL] [Abstract][Full Text] [Related]
2. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
Front Immunol; 2021; 12():667989. PubMed ID: 33953728
[TBL] [Abstract][Full Text] [Related]
3. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
5. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
6. A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes.
Roep BO; Kracht MJ; van Lummel M; Zaldumbide A
Curr Opin Immunol; 2016 Dec; 43():67-73. PubMed ID: 27723537
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".
Kent SC; Mannering SI; Michels AW; Babon JAB
Curr Diab Rep; 2017 Sep; 17(10):95. PubMed ID: 28864875
[TBL] [Abstract][Full Text] [Related]
8. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
9. Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.
James EA; Pietropaolo M; Mamula MJ
Diabetes; 2018 Jun; 67(6):1035-1042. PubMed ID: 29784651
[TBL] [Abstract][Full Text] [Related]
10. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
[TBL] [Abstract][Full Text] [Related]
11. Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes.
Mannering SI; Di Carluccio AR; Elso CM
Diabetologia; 2019 Mar; 62(3):351-356. PubMed ID: 30402774
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
Mallone R; Brezar V; Boitard C
Clin Dev Immunol; 2011; 2011():513210. PubMed ID: 21785617
[TBL] [Abstract][Full Text] [Related]
13. Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects.
Arif S; Pujol-Autonell I; Kamra Y; Williams E; Yusuf N; Domingo-Vila C; Shahrabi Y; Pollock E; Khatri L; Peakman M; Tree T; Lorenc A
Front Immunol; 2021; 12():675746. PubMed ID: 34262563
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Enrichment of Diabetogenic T Cells.
Thelin MA; Kissler S; Vigneault F; Watters AL; White D; Koshy ST; Vermillion SA; Mooney DJ; Serwold T; Ali OA
Diabetes; 2017 Aug; 66(8):2220-2229. PubMed ID: 28396510
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modifications contribute to neoepitopes in Type-1 diabetes: Challenges for inducing antigen-specific tolerance.
Balakrishnan S; Kumar P; Prabhakar BS
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140478. PubMed ID: 32599298
[TBL] [Abstract][Full Text] [Related]
16. Insulin and type 1 diabetes: immune connections.
Culina S; Brezar V; Mallone R
Eur J Endocrinol; 2013 Feb; 168(2):R19-31. PubMed ID: 23065992
[TBL] [Abstract][Full Text] [Related]
17. HIPs and HIP-reactive T cells.
Wiles TA; Delong T
Clin Exp Immunol; 2019 Dec; 198(3):306-313. PubMed ID: 31132145
[TBL] [Abstract][Full Text] [Related]
18. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
19. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
[TBL] [Abstract][Full Text] [Related]
20. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
[Next] [New Search]